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In a previous study (Rafla et al., 1987), it was found that
recurrence after radical cystectomy in bilharzial bladder
cancer during the first year after the operation is related to
tumour grade (G) coded 1, 2 or 3, tumour stage (T) coded 1,
2, 3 or 4, both defined according to the TNM classification
of UICC (UICC, 1979), tumour size expressed as the largest
diameter in cm (D), presence or absence of renal insufficiency
(RI) and of regional lymph node involvement (N), both
coded 1.0.
A simple linear function X of these factors
(X = 10G + 5T + 6RI + ID + 4N) was proposed to discrimi-
nate between patients with more than 1 year recurrence-free
survival and those who developed a recurrence during the
first year after radical cystectomy; recurrence being defined as
a local recurrence or appearance of new metastasis as dis-
tance. Patients with scores less than or equal to 39 were
classified in the good prognosis group, whereas those with
scores greater than 39 were classified in the bad prognosis
group.
The aim of the present study is to evaluate the qualities of
this model on a new sample of bilharzial bladder cancer
patients subjected to radical cystectomy, a so called test
sample, different from the learning sample which was used to
establish the model.
Data were collected retrospectively from records of
patients registered at the NCI of Cairo and restricted to
those aged more than 20 years, with bladder cancer
(confirmed by histopathological analysis of surgical speci-
men) associated with schistosomiasis (as evidenced by detec-
tion of ova of schistosoma haematobium in urine or in the
surgical specimen) who underwent radical cystectomy in the
period January 1984 to December 1985 at the NCI of Cairo,
and for whom a follow-up for at least 1 year after surgery
was feasible. One hundred and fifty subjects were eligible for
the study. At least one studied factor was missing in the
record of 13 patients. For 15 patients, follow-up could not be
evaluated. Consequently 122 patients were included for the
analysis (81% of the eligible patients). The validation was
performed on this new sample through a retrospective study
to avoid the delay necessary for follow-up of patients. How-
ever, the collected data were registered at the NCI before
determination of the prognostic factors and elaboration of
the discriminant function. Therefore, registration of data in
patients' records could not have been influenced by
knowledge of the prognostic factors used in the discriminant
function. Contrary to the previous study (Rafla et al., 1987),
no subject selection was performed. It can thus be assumed
that the studied sample was representative of patients with
bilharzial bladder cancer diagnosed at the NCI, who under-
went radical cystectomy and for whom follow-up was feasible
at the NCI of Cairo.
The characteristics of the 122 evaluable patients are sum-
marised in Table I. Table II shows the distribution of the five
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Table I Distribution of patient characteristics
Variable Number ofcases Percentage
Sex
Male 91 75
Female 31 25
Tumour location
Vault 24 20
Anterior 32 26
Posterior 42 34
Lateral 19 16
Trigone 5 4
Tumour stage
Ti 0 0
T2 3 2
T3 102 84
T4 17 14
Histopathology of
the tumour
Squamous 100 82
Transitional 16 13
Adenocarcinoma 6 5
Tumour grade
G1 42 34
G2 52 43
G3 28 23
Lymph node involvement
No 103 84
Yes 19 16
Metastasis
No 120 98
Yes 2 2
Renal insufficiency
No 84 69
Yes 38 31
Type ofurinary diversion
Rectal bladder 83 68
Ileal conduit 10 8
Ileocaecal conduit 7 6
Uretero-cutaneous 22 18
Range Mean s.d.
Age (years) 23-70 48.2 9.8
Tumour diameter (cm) 1-14 5.9 2.1
prognostic factors among patients who survived free of recur-
rence 1 year after the operation (50 patients) and those who
developed recurrence during the first year after the operation
(72 patients).
Estimated outcome was determined for each patient by
calculating his or her score and applying the above rule.
Estimated outcome was then displayed as a function of the
actual follow-up status obtained through follow-up in a two-
way table. The quality of the classification procedure was
assessed by its sensitivity and specificity. Sensitivity was
defined as the ability of the discriminant function to classify
in the bad prognosis group patients who developed recur-
rence within 1 year after radical cystectomy and specificity as
its ability to classify in the good prognosis group patients
with a survival of more than 1 year without recurrence after
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Table II Distribution of the five prognostic factors according to the
actual status of the patients one year after the radical cystectomy
Patients without Patients with
recurrence recurrence
Factors (50patients) (72patients)
Diameter of the tumour (cm)
Range 2-14 1-12
Mean 5.7 6.2
s.d. 2.2 2.0
Number % Number %
Tumour stage
TI 0 0 0 0
T2 2 4 1 1
T3 42 84 60 83
T4 6 12 11 16
Tumour grade
G1 29 58 13 18
G2 18 36 36 50
G3 3 6 23 32
Lymph node involvement
No 48 96 55 76
Yes 2 4 17 24
Renal insufficiency
No 40 80 44 61
Yes 10 20 28 39
radical cystectomy. The prognostic precision of the model
was the percentage of well classified patients in the whole
sample. By analogy with the definition used in epidemiology
(Cornfield, 1951), a relative risk K was estimated by the ratio
of the proportion of patients classified in the bad prognosis
group who developed recurrence to the same proportion in
the good prognosis group. All these quantities, mean and
95% confidence interval (95% CI) were estimated from the
two-way table displaying estimated and actual outcomes
(Jenicek & Cleroux, 1982).
Among the 72 patients who developed recurrence during
the first year of the operation, 67 were classified in the bad
prognosis group, leading to a sensitivity of 93% (95% CI
83.5-97.5%). Among the 50 patients who did not develop
recurrence during the first year after the operation, 40 were
classified in the good prognosis group, leading to a specificity
of 80% (95% CI 69-91%). The estimate of the prognostic
precision of this model was 88% (95% CI 82-94%). From
this table, relative risk was estimated to be about 8 (95% CI
5-13). It means that a patient had 8 times more chance of
developing recurrence when classified in the bad prognosis
group than when classified in the good prognosis group. The
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observed rate of recurrence 1 year after radical cystectomy
was 59% in our sample (95% CI 50-68%). In addition to
the 72 patients who developed recurrence during the first
year following radical cystectomy, 15 developed recurrence
between 13 and 24 months after radical cystectomy.
Therefore, out of all recurrences, 83% (95% CI 75-91%)
occurred during the first year after radical cystectomy, in
agreement with the previously published figure of 90.6% of
recurrence during the first year after the operation (El-
Bolkainy & Chu, 1981).
Positioning the cut-off point at 39 (Rafla et al., 1987) was
a critical issue to discriminate between the good and bad
prognosis groups. In fact, change in the cut-off point led to
adverse variations in sensitivity and specificity, as shown in
Figure 1. When the cut-off point was moved from 39 to 35,
the sensitivity of the model increased only from 93 to 94%,
while its specificity decreased from 80 to 54%. In the same
way, if the cut-off point moved from 39 to 42, the sensitivity
of the model decreased from 93 to 65%, whereas its
specificity increased only from 80 to 84%. This demonstrated
that a small variation of the limit in each direction produced
only a small increase (less than 5%) of either sensitivity or
specificity, with a concomitant large loss (more than 25%) in
either specificity or sensitivity. In our case, we chose the
cut-off point which had an optimum sensitivity without a
notable loss in specificity. Due to this high sensitivity few
patients who underwent recurrence during the first year after
radical cystectomy will escape classification in the bad prog-
nosis group. This should lead to adjuvant treatment and
more frequent follow-up by the physicians for patients who
need it.
Although the purpose of this work was not to re-evaluate
the discriminant function, a significant difference was
observed between the groups of patients who recurred and
those who did not for tumour grade, renal insufficiency and
lymph node involvement through the x2 method and for
tumour diameter through the Wilcoxon rank test (Siegel,
1956). Conversely, no difference was observed for tumour
stage, which could be accounted for by random sampling and
small sample size. When we tried to use tumour grade only,
tumour grade with either lymph node involvement or renal
insufficiency, we could achieve either a high sensitivity with a
very poor specificity or a high specificity at the expense of a
very low sensitivity. The corresponding results were similar to
or even worse than those obtained when moving the cut-off
point value.
In conclusion, the model appears to be suitable for prac-
tical use with a sensitivity of 93% and a specificity of 80%.
The use of the discriminant function by clinicians for the
management of patients according to their individual prog-
nosis should be recommended.
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Figure 1 Variation of sensitivity and specificity as a function of cut-off point value.RECURRENCE IN BILHARZIAL BLADDER CANCER 927
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